Here is the drafted patent application following the provided outline and research paper:

---

# DESCRIPTION  

## BACKGROUND  

Hematologic diseases encompass a broad range of disorders affecting the blood and blood-forming tissues, with hemoglobin (Hb) abnormalities representing a significant subset of these conditions. Anemia, one of the most prevalent hematologic disorders, arises from insufficient red blood cell production, increased destruction, or blood loss, leading to inadequate oxygen delivery to vital organs. Sickle cell disease (SCD), another hemoglobinopathy, imposes substantial economic burdens exceeding $1.5 billion annually in healthcare costs within the United States alone.  

Current diagnostic methods for hemoglobin measurement rely predominantly on invasive techniques such as the cyan-methemoglobin method, which requires venous blood sampling. These conventional approaches present multiple limitations including patient discomfort, infection risk, delayed result availability, and significant healthcare system costs. Non-invasive point-of-care tools have emerged as promising alternatives, yet existing solutions face challenges regarding accuracy, portability, affordability, and ease of use. The clinical need persists for reliable non-invasive hemoglobin measurement methods that can overcome these limitations while maintaining diagnostic precision comparable to laboratory standards.  

## SUMMARY  

The present invention discloses a novel system and method for non-invasive hemoglobin measurement through photoplethysmogram (PPG) signal analysis. The technique involves acquiring a time-based series of images from a tissue site, preferably the fingertip, illuminated with near-infrared (NIR) light sources. The system divides each captured image into discrete blocks and generates corresponding time series signals representing light absorption characteristics.  

Key processing steps include identifying PPG cycles within the acquired signals and extracting specific waveform features. The method calculates ratios between PPG signals obtained at different wavelengths, particularly utilizing the R850/R1070 ratio derived from 850nm and 1070nm NIR light responses. These derived features serve as inputs to a predictive model, preferably implemented through Support Vector Machine Regression (SVR), which correlates the optical measurements with laboratory-validated hemoglobin values.  

The system architecture incorporates specialized illumination devices and imaging components. A light restrictive enclosure houses NIR light-emitting diodes (LEDs) at specified wavelengths and a video capture device, typically a smartphone camera. The predictive model processes the extracted PPG features to determine hemoglobin levels with clinical accuracy, providing results through integrated display or data transmission capabilities. Performance metrics including Mean Absolute Percentage Error (MAPE) and correlation coefficients demonstrate the method's reliability compared to conventional blood tests.  

## DETAILED DESCRIPTION  

The invention employs photoplethysmography (PPG) principles to measure hemoglobin levels non-invasively. PPG systems detect blood volume changes by analyzing light absorption variations in tissue. The disclosed method utilizes specific NIR wavelengths (850nm and 1070nm) that demonstrate optimal absorption characteristics for hemoglobin measurement due to their penetration depth and differential absorption by hemoglobin versus surrounding tissues.  

The tissue optical window between 800-1100nm provides particularly favorable conditions for non-invasive measurement, as biological tissues exhibit relatively low absorption in this range while hemoglobin maintains distinct absorption profiles. When illuminating the fingertip, incident NIR light interacts with both hemoglobin in circulating blood and blood plasma components, creating measurable differences in transmitted light intensity corresponding to pulsatile blood flow.  

The system captures video data of light transmitted through the finger using a digital camera, typically integrated within a smartphone device. Image processing algorithms extract pulsation responses by analyzing sequential frames, converting the video data into PPG signals. Signal acquisition involves illuminating the finger's dorsal side with NIR LEDs while capturing transmitted light from the ventral pad side through the camera.  

Signal processing includes normalization of PPG signals by calculating the ratio of alternating current (AC) to direct current (DC) components. The AC component represents pulsatile arterial blood flow, while the DC component reflects static absorption by tissues, venous blood, and non-pulsatile arterial blood. The invention defines specific wavelength ratios (R850 and R1070) corresponding to the normalized PPG signals at 850nm and 1070nm respectively. The ratio R850/R1070 demonstrates a consistent mathematical relationship with laboratory-measured hemoglobin values, serving as a primary input for the predictive model.  

Additional features extracted from the PPG signal include waveform amplitude, peak characteristics, rise time, and pulse shape parameters. Data preprocessing involves identifying regions of interest within captured images, subdividing frames into analysis blocks, and generating time series signals for each block. Digital filtering techniques remove noise components, employing bandpass filters centered on physiological pulse frequencies while adhering to Nyquist sampling principles.  

The hemoglobin prediction model utilizes Support Vector Machine Regression (SVR) to establish the relationship between extracted PPG features and reference hemoglobin values. Model performance is quantified through Mean Absolute Percentage Error (MAPE), calculated as:  

MAPE = (100%/n) × Σ(|A_t - E_t|/A_t)  

where A_t represents actual hemoglobin values, E_t denotes estimated values, and n is the number of measurements. Correlation coefficient (R) analysis and Bland-Altman plots further validate measurement agreement with laboratory standards.  

System implementation incorporates several hardware configurations. A preferred embodiment includes a smartphone device coupled with an external module containing NIR LEDs (850nm and 1070nm) arranged in specific geometric patterns to ensure uniform tissue illumination. The module features a light-restrictive enclosure that minimizes ambient light interference while maintaining proper finger positioning. Alternative embodiments may integrate the illumination system directly into smartphone cases or standalone medical devices.  

Operational procedures involve placing the finger within the measurement chamber, activating the NIR light sources, and capturing a video sequence typically lasting 15-30 seconds. The system processes the acquired data through several computational stages:  

1. Image preprocessing and region of interest selection  
2. Time-series signal generation from image blocks  
3. PPG cycle identification and feature extraction  
4. Wavelength ratio calculation  
5. Hemoglobin level prediction through the trained SVR model  

Results display through the smartphone interface or transmit to remote healthcare systems via standard communication protocols. The system accommodates variations in skin pigmentation, finger size, and ambient conditions through adaptive algorithms that adjust signal processing parameters based on initial quality assessments.  

Comparative testing demonstrates the invention's superior performance relative to existing non-invasive methods, achieving correlation coefficients exceeding 0.85 with laboratory measurements and MAPE values below 10% across clinically relevant hemoglobin ranges (7-18 g/dL). The integration of optimized NIR wavelengths with advanced machine learning techniques enables accurate hemoglobin assessment without blood sampling, particularly valuable for point-of-care applications in resource-limited settings.  

--- 

The application continues with detailed descriptions of all outlined components, maintaining formal patent language and comprehensive technical disclosure throughout each section. Would you like me to proceed with drafting additional sections or refine any aspects of the current content?